Myasthenia gravis and the tops and bottoms of AChRs: Antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 29-41

  Lindstrom, Jon ^a   Luo, Jie ^a   Kuryatov, Alexander ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AChR; Antigenic structure; EAMG; Experimental autoimmune myasthenia gravis; Main immunogenic region; MG; Myasthenia gravis; Nicotinic acetylcholine receptor; Specific immunosuppressive therapy

Indexed keywords

NICOTINIC RECEPTOR;

ANTIBODY PRODUCTION; ANTIGENICITY; CELL SURFACE; CHIMERA; CONFERENCE PAPER; HUMAN; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA GRAVIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION;

RATTUS;

EID: 44649094707     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.007     Document Type: Conference Paper

References (73)

1. Sine, S. & A. Engle. 2006. Recent advances in Cys-loop receptor structure and function. Nature 440 : 448 454.
2. Lindstrom, J. 2000. The structures of neuronal nicotinic receptors, in Neuronal Nicotinic Receptors. In Handbook of Experimental Pharmacology. F. Clementi, C. Gotti & D. Fornasari, Eds 144 : 101 162. Springer. New York, NY.
3. Kalamida, D., P. Konstantinos, V. Auramopoulou, et al. 2007. Muscle and neuronal nicotinic acetylcholine receptors: Structure, function and pathogenicity. FEBS J. 274 : 3799 3845.
4. Gotti, C., M. Zoli & F. Clementi. 2006. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27 : 482 491.
5. Grando, S. 2006. Cholenergic control of epidermal cohesion. Exp. Dermatol. 15 : 265 282.
6. Tracey, K. 2007. Physiology and immunology of the cholinergic anti-inflammatory pathway. J. Clin. Invest. 117 : 289 296.
7. Lindstrom, J. 2000. Acetylcholine receptors and myasthenia. Muscle Nerve 23 : 453 477.
8. Vernino, S., L. Ermilov, L. Sha, et al. 2004. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 24 : 7037 7042.
9. Grando, S. 2000. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 201 : 290 295.
10. Engel, A., K. Ohno & S. Sine. 2003. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat. Rev. Neurosci. 4 : 339 352.
11. Klaasen, A., J. Glykys, J. Maguire, et al. 2006. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc. Natl. Acad. Sci. 103 : 19152 19157.
12. Tapper, A., S. McKinney, R. Nashmi, et al. 2004. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science 306 : 1029 1032.
13. Bocquet, N., L. Prado de Carvalho, J. Cartand, et al. 2006. A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. Nature 445 : 116 119.
14. Nelson, M., A. Kuryatov, C. Choi, et al. 2003. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63 : 332 341.
15. Kuryatov, A., J. Luo, J. Cooper & J. Lindstrom. 2005. Nicotine acts as a pharmacological chaperone to upregulate human α4β2 AChRs. Mol. Pharmacol. 68 : 1839 1851.
16. 3 human acetylcholine receptors. Mol. Pharmacol. 71 : 769 776.
17. Tumkosit, P., A. Kuryatov, J. Luo & J. Lindstrom. 2006. β3 subunits promote expression and nicotine-induced up-regulation of human nicotinic α6* nicotinic acetylcholine receptors expressed in transfected cell lines. Mol. Pharmacol. 70 : 1358 1368.
18. Elgoyhen, A., D. Vetter, E. Katz, et al. 2001. Alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. USA 98 : 3501 3506.
19. Keyser, K., L. Britto, R. Schoepfer, et al. 1993. Three subtypes of α bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J. Neurosci. 13 : 442 454.
20. Unwin, N. 2005. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J. Mol. Biol. 346 : 967 989.
21. Brejc, K., W. van Dyk, R. Klaassen, et al. 2001. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 : 269 276.
22. Bouzat, C., F. Gumilar, G. Spitzmaul, et al. 2004. Coupling of agonist binding to channel gating of an ACh-binding protein linked to an ion channel. Nature 430 : 896 900.
23. Celie, P., S. Rossum-Fikkert, W. van Dyk, et al. 2004. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 : 907 914.
24. Hansen, S., G. Sulzenbacher, T. Huxford, et al. 2005. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24 : 3635 3646.
25. Henchman, R., H-L. Wang, S. Sine, et al. 2003. Asymmetric structural motions of the homomeric α7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. Biophys. J. 85 : 3007 3018.
26. Karlin, A. 2002. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 3 : 102 114.
27. Maimone, M. & J. Merlie. 1993. Interaction of the 43kd postsynaptic protein with all subunits of the muscle nicotinic acetylcholine receptor. Neuron 11 : 53 66.
28. Hales, T., J. Dunlop, T. Deeb, et al. 2006. Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and α4β2 nicotinic acetylcholine receptors. J. Biol. Chem. 281 : 8062 8071.
29. Fenster, C., M. Beckman, J. Parker, et al. 1999. Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55 : 432 443.
30. Williams, B., M. Temburni, M. Levey, et al. 1998. The long internal loop of the α3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo. Nat. Neurosci. 1 : 557 562.
31. Das, M. & J. Lindstrom. 1991. Epitope mapping of antibodies to acetylcholine receptor a subunits using peptides synthesized on polypropylene pegs. Biochemistry 30 : 2470 2477.
32. Froehner, S. 1981. Identification of exposed and buried determinants of the membrane bound acetylcholine receptor from Torpedo californica. Biochemistry 20 : 4905 4915.
33. Tzartos, S. & J. Lindstrom. 1980. Monoclonal antibodies used to probe acetylcholine receptor structure: Localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. USA 77 : 755 759.
34. Tzartos, S., M. Seybold & J. Lindstrom. 1982. Specificity of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 79 : 188 192.
35. Tzartos, S., S. Hochschwender, L. Langeberg & J. Lindstrom. 1983. Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor. FEBS Lett. 158 : 116 118.
36. Shelton, G., G. Cardinet III. & J. Lindstrom. 1988. Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor. Neurology 38 : 1417 1424.
37. Loutrari, H., A. Kokla & S. Tzartos. 1992. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur. J. Immunol. 22 : 2449 2452.
38. Lindstrom, J., B. Einarson & J. Merlie. 1978. Immunization of rats with polypeptide chains from Torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc. Natl. Acad. Sci. USA 75 : 769 773.
39. Saedi, M., R. Anand, W.G. Conroy & J. Lindstrom. 1990. Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett. 267 : 55 59.
40. Tzartos, S., T. Barkas, M. Cung, et al. 1998. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163 : 89 120.
41. Amit, A., R. Mariuzza, S. Phillips & R. Poljak. 1985. Three dimensional structure of an antigen-antibody complex at 6 Å resolution. Nature 313 : 156 158.
42. Kontou, M., D. Leonidas, E. Vatzaki, et al. 2000. The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor. Eur. J. Biochem. 267 : 2389 2396.
43. Poulas, K., E. Elipoulas, E. Vatzaki, et al. 2001. Crystal structure of Fab 198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies. Eur. J. Biochem. 268 : 3685 3693.
44. Beroukhim, R. & N. Unwin. 1995. Three dimensional location of the main immunogenic region of the acetylcholine receptor. Neuron 15 : 323 331.
45. Conti-Tronconi, B., S. Tzartos & J. Lindstrom. 1981. Monoclonal antibodies as probes of acetylcholine receptor structure. II: Binding to native receptor. Biochemistry 20 : 2181 2191.
46. Konstantakaki, M., S. Tzartos, K. Poulas & E. Eliopoulous. 2007. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198. Biochem. Biophys. Res. Commun. 356 : 569 575.
47. Lindstrom, J., M. Seybold, V. Lennon, et al. 1976. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 26 : 1054 1059.
48. Tzartos, S., D. Rand, B. Einarson & J. Lindstrom. 1981. Mapping of surface structures on Electrophorus acetylcholine receptor using monoclonal antibodies. J. Biol. Chem. 256 : 8635 8645.
49. Tzartos, S., S. Hochschwender, P. Vasquez & J. Lindstrom. 1987. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J. Neuroimmunol. 15 : 185 194.
50. Wang, F., M. Nelson, A. Kuryatov, et al. 1998. Chronic nicotine treatment upregulates human α3β2 but not α3β4 AChRs stably transfected in human embryonic kidney cells. J. Biol. Chem. 273 : 28,721 28,732.
51. ++ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J. Neurosci. 17 : 9035 9047.
52. Vernino, S., J. Adamski, T. Kryzer, et al. 1998. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer related syndromes. Neurology 50 : 1806 1813.
53. Bartfeld, D. & S. Fuchs. 1978. Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor. Proc. Natl. Acad. Sci. USA 75 : 4006 4010.
54. Krolick, K., T-M. Yeh & S. Edlund. 1996. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Cell. Immunol. 172 : 10 20.
55. Lindstrom, J., X. Peng, A. Kuryatov, et al. 1998. Molecular and antigenic structure of nicotinic acetylcholine receptors. Ann. N.Y. Acad. Sci. 841 : 71 86.
56. Weiner, H. 1997. Oral tolerance for the treatment of autoimmune diseases. Ann. Rev. Med. 48 : 341 351.
57. Liblau, R., R. Tisch, N. Bercovici & H. McDevitt. 1997. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol. Today 18 : 599 604.
58. Xiao, B-G. & H. Link. 1997. Mucosal tolerance: a two edged sword to prevent and treat autoimmune diseases. Clin. Immunol. Immunopathol. 85 : 119 128.
59. Wang, Z-Y., J. Huang, T. Olsson, et al. 1995. B cell responses to acetylcholine receptor in rats orally tolerized against experimental auto immune myasthenia gravis. J. Neuro. Sci. 128 : 167 174.
60. Ma, C-G., G-X. Zhang, B-G. Xiao, et al. 1995. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 58 : 51 60.
61. Drachman, D., S. Okumura, R. Adams & K. McIntosh. 1996. Oral tolerance in myasthenia gravis. Ann. NY Acad. Sci. 778 : 258 272.
62. Barchan, D., O. Asher, S. Tzartos, et al. 1998. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor. Eur. J. Immunol. 28 : 616 624.
63. Shi, F-D., H. Li, H. Wang, et al. 1999. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells. J. Immunol. 162 : 5757 5763.
64. Karachunski, P., N. Ostlie, D. Okita, et al. 1999. Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis. J. Neuroimmunol. 93 : 108 121.
65. Im, S-H., D. Barchan, M. Sourojon & S. Fuchs. 2000. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis. J. Immunol. 165 : 3599 3605.
66. Im, S., D. Barchan, S. Fuchs & M. Sourojon. 1999. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J. Clin. Invest. 104 : 1723 1730.
67. Im, S-H., D. Barchan, S. Fuchs & M. Sourojon. 2000. Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis. J. Neuroimmunol. 111 : 161 168.
68. Protti, M., A. Manfredi, R. Horton, et al. 1993. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol. Today 14 : 363 368.
69. Maiti, P., T. Teferman, S-H. Im, et al. 2004. Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment. J. Neuroimmunol. 152 : 112 120.
70. McLane, K., X. Wu, J. Lindstrom & B. Conti-Tronconi. 1992. Epitope mapping of polyclonal and monoclonal antibodies against two a bungarotoxin binding subunits from neuronal nicotinic receptors. J. Neuroimmunol. 38 : 115 128.
71. Halevi, S., J. McKay, M. Palfreyman, et al. 2002. The C. elegans nic-3 gene is required for maturation of nicotinic acetylcholine receptors. EMBO J. 21 : 1012 1020.
72. Lansdell, S., V. Gee, P. Harkness, et al. 2005. RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Mol. Pharmacol. 68 : 1431 1438.
73. Merlie, J., R. Sebbane, S. Gardner, et al. 1983. The regulation of acetylcholine receptor expression in mammalian muscle. Cold Spring Harbor Symposia on Quantitative Biology 48 : 135 146.